hairy cell leukemia


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to hairy cell leukemia: Cladribine

hairy cell leukemia

[¦her·ē ‚sel lü′kē·mē·ə]
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Thus, to meet the food demand of the ever-increasing population, chemical fertilizers are increasingly used, which is expected to increase the prevalence of hairy cell leukemia which, in turn, will lead the expansion of the global hairy cell leukemia therapeutics market at a CAGR of over 6% during the forecast period.
According to the company, Lumoxiti (moxetumomab pasudotox-tdfk) injection for intravenous use has been approved for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.
Hairy cell leukemia (HCL), on the other hand, is a chronic B-lymphoid leukemia that was originally described in 1958 by Bouroncle et al.
Analysis of [CD10.sup.+] hairy cell leukemia. Am J Clin Pathol.
This report provides comprehensive information on the therapeutic development for Hairy Cell Leukemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Ozer, "Acute myeloid leukemia following treatment with cladribine for hairy cell leukemia: a case report and review of the literature," Leukemia and Lymphoma, vol.
Distinction from hypocellular myelodysplastic syndrome (MDS), hypocellular hairy cell leukemia and aplastic anemia can usually be achieved by integration of morphology, immunohistochemistry, immunophenotyping, cytogenetics and molecular studies.
We report 2 cases of melioidosis and hairy cell leukemia in travelers returning from Thailand.
Although the etiology of paraneoplastic vasculitis is not yet clearly known, suggested mechanisms are: (i) vascular damage caused by cross-reactions between antibodies against tumor cells and the vascular endothelium (ii) vascular inflammation caused by immune complexes involving tumor antigens (iii) direct vascular damage caused by the hairy cells in hairy cell leukemia. Autoantibodies, such as rheumatoid factor, the antineutrophil cytoplasmic antibody, and antinuclear antibodies, are negative in patients with paraneoplastic vasculitis.
Until recently, there were only three DBQs for disabilities--ischemic heart disease, hairy cell leukemia and Parkinson's disease.
However, the gene expression profile of the icukemic cells is not the same as that of the normal counterpart and displays many similarities and differences (7), (24-27) Gene expression profile of the leukemic B cells in fbllicular lymphorna, hairy cell leukemia and CLL has been shown to resemble the germinal center or the memory stage of differentiati on (7), (24), (28), (29).